RadNet, Inc. (NASDAQ:RDNT) VP Mark Stolper sold 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 30th. The shares were sold at an average price of $10.19, for a total value of $101,900.00. Following the completion of the sale, the vice president now owns 145,319 shares of the company’s stock, valued at $1,480,800.61. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

RadNet, Inc. (NASDAQ:RDNT) traded up 2.48% on Wednesday, reaching $10.35. The company had a trading volume of 551,042 shares. RadNet, Inc. has a one year low of $5.25 and a one year high of $10.40. The company has a 50-day moving average of $8.06 and a 200 day moving average of $6.89. The stock has a market cap of $489.20 million, a price-to-earnings ratio of 54.47 and a beta of 1.01.

RadNet (NASDAQ:RDNT) last announced its quarterly earnings data on Tuesday, August 8th. The medical research company reported $0.11 EPS for the quarter, beating the consensus estimate of $0.04 by $0.07. RadNet had a net margin of 1.04% and a return on equity of 19.98%. The business had revenue of $230 million during the quarter, compared to the consensus estimate of $230.32 million. During the same period in the previous year, the business earned $0.09 earnings per share. The company’s revenue was up 5.2% on a year-over-year basis. On average, equities research analysts predict that RadNet, Inc. will post $0.29 EPS for the current year.

WARNING: “Mark Stolper Sells 10,000 Shares of RadNet, Inc. (RDNT) Stock” was posted by American Banking News and is owned by of American Banking News. If you are accessing this article on another domain, it was illegally copied and republished in violation of international trademark & copyright law. The legal version of this article can be accessed at https://www.americanbankingnews.com/2017/08/30/mark-stolper-sells-10000-shares-of-radnet-inc-rdnt-stock.html.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. TFS Capital LLC increased its position in shares of RadNet by 238.0% in the first quarter. TFS Capital LLC now owns 121,948 shares of the medical research company’s stock valued at $719,000 after buying an additional 85,872 shares in the last quarter. American International Group Inc. increased its position in shares of RadNet by 7.0% in the first quarter. American International Group Inc. now owns 22,857 shares of the medical research company’s stock valued at $135,000 after buying an additional 1,500 shares in the last quarter. Cadence Capital Management LLC increased its position in shares of RadNet by 32.5% in the first quarter. Cadence Capital Management LLC now owns 171,565 shares of the medical research company’s stock valued at $1,012,000 after buying an additional 42,107 shares in the last quarter. Prudential Financial Inc. increased its position in shares of RadNet by 29.2% in the first quarter. Prudential Financial Inc. now owns 17,710 shares of the medical research company’s stock valued at $104,000 after buying an additional 4,000 shares in the last quarter. Finally, Globeflex Capital L P increased its position in shares of RadNet by 15.7% in the first quarter. Globeflex Capital L P now owns 138,705 shares of the medical research company’s stock valued at $818,000 after buying an additional 18,800 shares in the last quarter. Institutional investors and hedge funds own 48.81% of the company’s stock.

RDNT has been the subject of a number of research analyst reports. Jefferies Group LLC upgraded RadNet from a “hold” rating to a “buy” rating and boosted their price target for the company from $7.00 to $12.00 in a report on Tuesday, August 22nd. Zacks Investment Research upgraded RadNet from a “sell” rating to a “hold” rating in a report on Wednesday, May 17th. BidaskClub upgraded RadNet from a “buy” rating to a “strong-buy” rating in a report on Thursday, August 24th. Finally, TheStreet upgraded RadNet from a “c” rating to a “b-” rating in a report on Thursday, August 24th. Two equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company. RadNet has an average rating of “Buy” and an average price target of $9.42.

About RadNet

RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.

Insider Buying and Selling by Quarter for RadNet (NASDAQ:RDNT)

Receive News & Ratings for RadNet Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet Inc. and related companies with MarketBeat.com's FREE daily email newsletter.